Abstract
Circadian rhythms play a critical role in regulating physiological and behavioral processes, with amplitude being a key parameter for their characterization. However, accurately quantifying circadian amplitude in natural settings remains a challenge, as traditional melatonin methods require lab settings and are often costly and time-consuming. Wearable devices are a promising alternative as they can collect consecutive 24-h data for multiple days. The most commonly used measure of circadian amplitude from wearable device data, relative amplitude, is subject to the masking effect of behaviors and fails to leverage the rich information in high-dimensional data, as it only uses the sum of activity counts in time windows of pre-specified lengths. Therefore, in this study, we firstly proposed a pipeline to derive a novel feature to characterize circadian amplitude, named circadian activity rhythm energy (CARE), which can well address the above-mentioned challenges by decomposing raw accelerometer time series data, and then we validated the new feature CARE by assessing its correlation with melatonin amplitude (Pearson’s r = 0.46, P = 0.007) in a dataset of 33 healthy participants. Secondly, we investigated its association with cognitive functions in two datasets: an adolescent dataset (Chinese SCHEDULE-A, n = 1,703) and an adult dataset (the UK Biobank dataset, n = 92,202), and we found that the CARE was significantly associated with the Global Executive Composite (β = 28.02, P = 0.016) in adolescents, and reasoning ability (OR = 0.01, P < 0.001), short-term memory (OR = 3.42, P < 0.001), and prospective memory (OR = 11.47, P < 0.001) in adults. And finally, we explored the causal relationship using Mendelian randomization analysis in the adult dataset. We identified one genetic locus with 126 SNPs associated with CARE using genome-wide association study (GWAS), of which 109 variants were used as instrumental variables to conduct causal analysis. The results suggested that CARE had a significant causal effect on reasoning ability (β = -59.91, P < 0.0001), short-term memory (β = 7.94, P < 0.0001), and prospective memory (β = 16.85, P < 0.0001). The findings suggested that CARE is an effective wearable-based metric of circadian amplitude with a strong genetic basis and clinical significance, and its adoption can facilitate future circadian studies and potential interventions to improve circadian rhythms and cognitive functions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by the National Key R&D Program of China (2018YFC0910500), National Natural Science Foundation of China (82073568), Shanghai Jiao Tong University (YG2016ZD04), Shanghai Municipal Health Commission (GWIV-36 and GWV-10.1-XK07), SJTU-Yale Collaborative Research Seed Fund, the Neil Shen's SJTU Medical Research, and Innovative Research Team of High-level Local Universities in Shanghai (SHSMU-ZDCX20211900).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Shanghai Children's Medical Center's Human Ethics Committee (SCMCIRB-K2018103; SCMCIRB-K2021070-2) and Shanghai Jiao Tong University School of Medicine (SJTUPN-202301).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The calculation algorithm of CARE has been revised.
Data Availability
The melatonin and adolescent datasets used in the current study are not publicly available but are available from the corresponding author (Fan Jiang) on reasonable request. The UK Biobank data that support the findings of this study are available from the UK Biobank project but restrictions apply to the availability of these data, which were used under license for the current study (application number: 57947), and so are not publicly available.
